Fallon Clinic and Fallon Community Health Plan
Worcester, Massachusetts, 01605, United States
NCT Number: NCT00043992
To examine the role of outdoor pollen grains and fungal spores in the exacerbation of asthma and to produce forecasting models to predict days of high concentration.
Looking for future studies?
Notify Me15 year–50 year
All sexes
Observational
Worcester, Massachusetts, 01605, United States
Asthma is a growing problem, and outdoor allergens play a role in exacerbation of many cases. A clearer understanding of this role and its magnitude, and a means of controlling the effects of outdoor allergen exposures is needed. We propose Poisson time-series and conditional panel studies to test these hypotheses: 1) The incidence of acute asthma attacks, as measured by urgent care inhalation treatments and hospitalizations for asthma, has a dose-dependent relationship with exposure to specific outdoor allergens; 2) Specific sensitization to outdoor allergens is a risk factor for having an acute attack; and 3) Exposure conditions that lead to acute asthma attacks can be forecast, creating an opportunity to reduce asthma morbidity and mortality ny targeting pretreatment and/or exposure controls.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Must be a member of the Fallon HMO and be treated for acute asthma exacerbation.
Looking for future studies?
Notify MeNational Institute of Environmental Health Sciences (NIEHS)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02227394
Asthma, Asthma Bronchial
Edegem, Antwerp, Belgium
View Trial DetailsNCT02809560
Asthma, Bronchial Diseases
Toulouse, France
View Trial DetailsNCT05091034
Asthma, Bronchial Diseases
New York, United States
View Trial DetailsNCT05853809
Asthma, Bronchial Diseases
Stockholm, Sweden
View Trial Details